The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if the usage of sugammadex would reduce the time to
return of bowel function when compared to standard of care (neostigmine/glycopyrrolate) when
used for neuromuscular blockade reversal in patients with open abdominal wall reconstruction
(AWR).